Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children—a systematic review of prospective trials
- 9 March 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 20 (6), 1135-1145
- https://doi.org/10.1007/s00520-012-1425-8
Abstract
There is no consensus on whether therapeutic intensity can be reduced safely in children with low-risk febrile neutropenia (FN). Our primary objective was to determine whether there is a difference in efficacy between outpatient and inpatient management of children with low-risk FN. Our secondary objective was to compare oral and parenteral antibiotic therapy in this population. We performed electronic searches of Ovid Medline, EMBASE, and the Cochrane Central Register of Controlled Trials, and limited studies to prospective pediatric trials in low-risk FN. Percentages were used as the effect measure. From 7,281 reviewed articles, 16 were included in the meta-analysis. Treatment failure, including antibiotic modification, was less likely to occur in the outpatient setting compared with the inpatient setting (15 % versus 28 %, P = 0.04) but was not significantly different between oral and parenteral antibiotic regimens (20 % versus 22 %, P = 0.68). Of the 953 episodes treated in the outpatient setting and 676 episodes treated with oral antibiotics, none were associated with infection-related mortality. Based on the combination of results from all prospective studies to date, outpatient and oral antibiotic management of low-risk FN are effective in children and should be incorporated into clinical care where feasible.Keywords
This publication has 49 references indexed in Scilit:
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young peopleEuropean Journal of Cancer, 2010
- Randomized Control Trial Comparing Oral Amoxicillin-clavulanate and Ofloxacin With Intravenous Ceftriaxone and Amikacin as Outpatient Therapy in Pediatric Low-risk Febrile NeutropeniaJournal of Pediatric Hematology/Oncology, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centresArchives of Disease in Childhood, 2007
- Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropeniaPediatric Blood & Cancer, 2007
- Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant diseaseCancer, 2003
- A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremiaThe Journal of Pediatrics, 1996
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986